ClinVar Miner

Submissions for variant NM_000251.2(MSH2):c.646-13T>C (rs761205332)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000521261 SCV000618012 uncertain significance not provided 2017-03-07 criteria provided, single submitter clinical testing This variant is denoted MSH2 c.646-13T>C or IVS3-13T>C and consists of a T>C nucleotide substitution at the -13 position of intron 3 of the MSH2 gene. This variant is predicted to damage the natural splice acceptor site and possibly cause abnormal splicing; however, in the absence of RNA or functional studies, the actual effect of this variant is unknown. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. MSH2 c.646-13T>C was not observed at a significant frequency in large population cohorts (Lek 2016, The 1000 Genomes Consortium 2015, NHLBI Exome Sequencing Project). The thymine (T) nucleotide that is altered is conserved across species. Based on currently available information, it is unclear whether MSH2 c.646-13T>C is pathogenic or benign. We consider it to be a variant of uncertain significance.
Color RCV000583363 SCV000690122 likely benign Hereditary cancer-predisposing syndrome 2017-06-02 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.